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Loss of glomerular responses to vasoconstrictor agents in
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Loss of glomerular responses to vasoconstrictor agents in rabbits
recovering from ARF. Glomerular responses to angiotensin II (All),
arginine vasopressin (AVP), and norepinephrine (NE) were estimated
in rabbits recovering from uranium—mediated nephropathy or ischemic
acute renal failure (ARF) to examine roles of intraglomerular events in
resistance to ARF. Uranyl acetate (UA, 0.8 mg/kg) produced ARF in
some animals but did not in others. Rabbits recovering from UA-
induced ARF were highly resistant to a rechallenge with a larger dose of
the agent (2 mg/kg). Their glomeruli did not respond to All, AVP and
NE in vitro. In animals having not experienced ARF following the
initial insult, however, resistance to the rechallenge was lower than in
animals recovering from ARF, and the glomerular response to contrac-
tile stimuli was well sustained. A two hour clamping of the renal artery
induced ARE in uninephrectomized rabbits. These animals were not
resistant to an additional ischcmia in the recovery phase, despite
inhibited glomerular contractile response to All. These data indicate a
nonspecific inhibition of glomerular responses to contractile stimuli in
the recovery phase of ARF. It is unlikely, however, that resistance to
ARF can be attributed to the loss of the glomerular contractile re-
sponse.
Recurrence of acute renal failure (ARF) appears to be an
unusual phenomenon [I]. A number of investigations demon-
strated that animals recovering from ARF are highly resistant to
a second challenge with the same or different agents [2—1 1], but
it is not a common feature of all models. The previous study
from this laboratory $1 showed in rabbits that uranyl
acetate—induced ARF protects glomerular filtration against a
rechallenge with a larger dose of the agent.
The mechanisms for acquired resistance to ARF have not
been well established. Wilkes et a! [71 noted that the gomerular
contractile response to angiotensin II is totally inhibited in rats
recovering from glycerol—induced ARF, and suggested that
glomerular refractoriness to angiotensin accounts, in part, for
resistance to a subsequent renal failure challenge in this model.
On the other hand, increased sympathetic nerve activity, and
elevated plasma levels of angiotensin II and vasopressin have
been demonstrated in clinical and experimental ARF [12—14],
though controversy still exists concerning their pathogenic
roles in ARF [15, 161. Scant information is available, however,
regarding glomerular reactivity to vasopressin and catechola-
mine in ARF-resistant animals.
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In the present work, the glomerular contractile response to
angiotensin II, arginine vasopressin or norepinephrine was
examined in rabbits recovering from uranyl acetate—induced or
ischemic ARF to explore role of intraglomerular events in
resistance to a subsequent renal failure challenge.
Methods
Studies were performed on 78 white rabbits, weighing ap-
proximately 3 kg and allowed free access to commercial rabbit
chow and drinking water. Following the i.v. injection of 0.8
mg/kg of body wt of uranyl acetate, a minimum dose to induce
ARF [8], pronounced azotemia (serum creatinine > 2 mg/lOO
ml) occurred in 26 of 49 rabbits examined (UA-ARF rabbits),
while the other 23 animals showed a slight increase in serum
creatinine (Non-IJA-ARF rabbits, serum creatinine < 2 mg/l00
ml). In another 11 animals, ischemic ARE was induced by a two
hour clamping of the renal artery 14 days after unilateral
nephrectomy, The remaining 18 healthy rabbits were used as
normal controls in the in vitro experiment, as described later.
The experiment consisted of measurements of the serum
creatinine concentration and plasma renin activity, and evalu-
ation of the glomerular contractile response to angiotensin II,
arginine vasopressin, or norepinephrine in vitro.
For statistical analysis, one—way analysis of variance and
paired or nonpaired Student's t-test were used, All data are
presented as the mean SEM.
Measurements of serum creatinine concentration and plasma
renin activity
Fourteen days after the initial injection of uranyl acetate, a
second dose of 2 mg/kg was given to eight UA-ARF and five
non-UA-ARF rabbits to examine whether or not they were
resistant to the rechallenge with a larger dose of the agent. in
five animals recovering from ischemic ARF, resistance to a
rechallenge with the renal artery clamping was evaluated. The
serum creatinine concentration was determined at appropriate
times by the colorimetric method [17] (Table 1). The plasma
renin activity was estimated only in uranium treated animals.
Blood for determination of the renin activity was collected in
chilled syringes containing EDTA and was immediately centri-
fuged at 4°C. The plasma renin activity was estimated by the
radioimmunoassay method, using Renin—Riakit (Dainabot Ja-
pan, Tokyo, Japan).
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Table 1. Serum creatinine concentration and plasma renin activity following uranyl acetate (UA) or renal ischemia
Before
insult
After the first insu1t After the second insult"
3 days 5 days3 days 5 days 14 days
Non..UAARFc (Nd = 5)
0.9 1.6 1.0 5.9Scre,
mg/100 ml 1•61g
PRAb 2.3 4.7 3.3 5.7
ng/ml/hr 077g -j-050g 178g
UA-ARF (N = 8)
Scr 0.9 5.5 1.0 1.6
PRA 1.6 3.6 2.0 3.8
Ischemic ARF (N = 5)
1.3 7.2 1.6 7.6Scr
Non-UA-ARF
vs.
UA-ARF
Scr N P < 0.05 NS P < 0.05
PRA NS NS P<0.01 NS
An i.v. injection of 0.8 mg/kg of UA or a two hour clamping of the renal artery was used as the first insult
An i.v. injection of 2 mg/kg of UA or a two hour clamping of the renal artery was used as the second insult
ARF, acute renal failure induced by the first insult
d N, number of animals
Sc, serum creatinine concentration
P < 0.01, as compared to the value before the first insult
g P < 0.05, as compared to the value before the first insult
"PRA, plasma renin activity
'P < 0.005, as compared to the value before the first insult
NS, not statistically significant
Glomerular responses to vasoconstrictor agents in vitro
Glomerular responses to vasoconstrictor agents were evalu-
ated in vitro 14 days after the initial ARF insult, a time at which
recovery from azotemia and renal damage has been found [8,
18—20]. In the uranium model, glomerular reactivity to anglo-
tensin II was examined in six rabbits per each of UA-ARF and
Non-UA-ARF groups. Six healthy rabbits were used as normal
controls. An additional six animals per group were used to
estimate the glomerular response to arginine vasopressin. In the
remaining normal and uranium treated rabbits, the response to
norepinephrine was evaluated. Furthermore, six ischemic ARF
animals were used to examine glomerular reactivity to angio-
tensin II in the recovery phase, a time at which resistance to a
second ischemic insult has not been demonstrated [11, 21].
For assessing glomerular responses to these vasoconstrictor
agents, the technique described by Wilkes et al [7] was modified
in this laboratory. Immediately after anesthesia was induced
with sodium pentobarbital (30 mg/kg of body wt, i.v.), nephrec-
tomy was performed without renal artery perfusion. The outer
cortex was incised into small pieces with a razor blade and
gently mashed on a stainless sieve of 115-mesh by finger tip.
The suspension of mashed tissue was passed through a series of
150- and 200-mesh sieves in succession. The tissue pieces
resting on the 200-mesh sieve were collected and suspended in
phosphate buffer saline, pH 7.5. The suspension was again
passed through the 200-mesh sieve. Tissues rested on the mesh
were collected, transferred to Eagle's minimal essential me-
dium (Eagle MEM "Nissui", Nissui Pharmaceutical Co., To-
kyo, Japan), and then centrifuged at 200 xg for one minute. The
precipitate was checked for purity in glomeruli using a phase
contrast microscope. Isolated glomeruli, freed of the Bowman's
capsule and arteriole, were resuspended in 36 ml of Eagle's
minimum essential medium, and 0.9 ml aliquots were measured
into separate tissue culture dishes. Less than 60 minutes were
required from induction of anesthesia to final separation of
glomeruli.
Angiotensin II, arginine vasopressin or norepinephrine
(Sigma Chemical Co., St. Louis, Missouri, USA) was added to
glomerular suspension to produce a final concentration range as
shown in Tables 2, 3 and 4. Samples were incubated for five, 10,
20 or 30 minutes at room temperature and then subjected to
fixation with 1% glutaraldehyde. Glomeruli were photographed
under a phase contrast microscope at 25 x power (Olympus
C-35A, Olympus, Tokyo, Japan). Finally photographs were
magnified 100 times, and the diameter of glomeruli was mea-
sured using a computerized image analyzer (Videoplan,
Kontron Co., Munich, FRG). As glomeruli were not always
circular, the measurement was made in the widest diameter on
the photographs. Approximately 100 glomeruli were measured
in each assay dish, and then the mean and SEM in each group
were calculated from the average values in the individual
animals. The measurement was performed by individuals with-
out any prior knowledge of the experiments to minimize ob-
server bias.
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Table 2. Glomerular diameter (sm) following angiotensin 11 (All) addition
Incubation time, mm
AII,M 0 5 10 20 30
Normal controls, N = 6
0 154 2.7 154 3.0 154 2.6 154 2.5 153 2.7
10_12 154 2.9 150 2.5a 148 2.5a 146 30b 147 23b
b_b 155 2.7 148 2.7a 147 2,8" 146 3.3" 147 28b
108 155 2.8 148 3.1" 146 2.9" 145 3.3" 147 32b10" 153 2.9 148 3.21 146 3.0" 145 3.1" 147 2.8"
Non-UA-ARF, N = 6
0 157 1.8 157 2.2 157 2.2 156 1.9 156 2.0
10—12 157 2,1 152 2.3a 150 2.6 150 3.1" 150 2.l
10'° 157 1.7 152 2.6a 150 2.6a 150 3.2a 150 2.6al0 156 1.6 151 2,7" 150 2,6a 149 3,1" 149 3.0"
10-6 157 2.3 150 3.0" 150 2.7a 149 3.1" 149 30b
UA-ARF, N = 6
0 153 2.0 153 1.6 153 2.0 153 1.8 154 1.6
10_12 154 1.9 153 1.6 154 1.4 154 1.7 153 1.9
10_'° 154 1.9 154 2.0 154 1.5 154 1.7 153 2.0
I0" 153 2.0 154 1.7 153 1.9 153 2.0 152 1.9
10—6 154 1.7 155 1.6 153 1.9 152 1.8 152 2.1
Ischemic ARF, N = 6
0 154 1.4 154 1.3 154 1.3 154 2.1 153 1.5
1012 154 1,2 154 1.4 154 1.7 153 2.2 153 2.0
10—6 154 1.5 155 1.6 154 1.5 153 1.0 152 1.8
a p < 0.05, as compared to time 0 and to dose 0
b P < 0.01 as compared with time 0 and to dose 0
Table 3. Glomerular diameter (/tm) following arginine vasopressin (AVP) addition
Incubation time, mm
AVP,M 0 5 10 20 30
Normal controls, N = 6
0 154 1.3 154 1.2 155 1.2 154 1.2 154 1.5iO 155 1.3 155 1.3 154 1.0 154 0.9 153 1.2
10_12 155 1.2 150 1.4 150 1.6 151 1.6 153 1.2
10-10 154 1.3 148 Ø,9 148 l.4a 149 2.la 150 2.010 154 1.4 147 1.2 147 1.3 148 l.8a 149 2.3a
l0_6 154 1.0 148 1.2 146 1.2" 147 l.6a 148 2.2"
Non-UA-ARF, N = 6
0 152 1.9 152 1.5 151 1.5 152 1.7 151 1.6
152 l.6 152 1.7 152 1.4 151 1.7 151 1.5
10_12 152 1.8 149 2.5a 148 2.0" 149 2.7 150 2.4
10_b 152 1.5 148 2.5a 146 2.4" 148 2.4" 150 2.410 152 1.8 147 2.4" 146 2.6" 147 2.7" 148 2.6"l0" 152 1.7 147 2.5" 145 2.7" 146 3.Oa 147 2.9"
UA-ARF, N = 6
0 158 2.1 157 2.6 157 2.6 158 2.5 158 2.6
158 2.7 158 2.3 158 2.5 157 2.7 157 2.5
1012 158 2.8 157 2.4 157 2.6 157 2.5 157 2.5100 158 2.4 157 2.6 157 2.3 158 2.6 157 2.4l0 158 2.5 157 2.6 158 2.5 157 2.6 157 2.6
10" 158 2.6 156 2.6 156 2.7 156 2.8 157 3.0
P < 0.05 as compared to time 0 and dose 0.
b P < 0.01 as compared with time 0 and dose 0.
Results pronounced [8, 18], the serum creatinine concentration in-
creased to more than 2 mg/100 ml in eight of 13 animals
Serum creatinine concentration and plasma renin activity examined (UA-ARF rabbits, serum creatinine 5.5 1.55
Five days after the i.v. injection of 0.8 mg/kg of uranyl mg/100 ml) (Table 1) but slightly increased in the remainder
acetate, a time at which renal damage has been found to be most (Non-UA-ARF rabbits, serum creatinine 1.6 0.08 mg/100 ml).
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Table 4. Glomerular diameter (Mm) following norepinephrine (NE) addition
NE,M
Incubation time, mm
0 5 10 20 30
Normal controls, N = 6
151 2.5
151 2.6
151 2.3
151 3.1
151 2.7
151 2.5
149 2.2a
146 2.8a
147 2.8a
146 2.7a
151 2.6
148 2.3a
145 2.7a
145 2.2a
144 2.5a
150 2.4
147 2.4a
144 3.1"
144 2.9"
142 27k'
151 2.7
149 2.3a
145 2.7"
143 28b
143 2.7"
0
10—10
10—8
10—6l0
Non-UA-ARF, N = 6
0
10-10
10—8
10-6
io—
UA-ARF, N = 6
150 1.9
150 2.0
150 2,0
150 2.1
149 2.3
151 2.1
148 1.8
144 1.8
144 2.0
143 2.5"
150 2.0
147 1.5
142 1.9
143 l.8
141 2.4"
149 2.1
146 1.0
141 1,9b
140 1.9"
139 2.2'
150 2.1
145 o.4
141 1.4"
140 1.4"
138 1.9"
0
10_toiO
10—6
10—i
151 1.8
152 1.5
151 1.8
152 1.6
152 1.7
152 1.8
152 1.7
152 1.6
151 1.8
151 1.6
151 1.8
152 1.7
151 1.6
152 1.4
150 1.9
151 1.7
151 1.8
151 1.6
150 1.8
150 1.9
151 1.7
151 1.6
151 1.7
150 1.7
149 1.9
a P < 0.05 as compared to time 0 and to dose 0bP < 0.01 as compared to time 0 and to dose 0
Fourteen days after the injection, serum creatinine was restored
to the pre-injection level. A rechallenge with 2 mg/kg of uranyl
acetate—induced ARF in rabbits having not experienced renal
failure following the initial insult, but did not in animals
recovering from prior ARF. The plasma renin activity increased
to a similar degree following the initial and second insults (Table
1). There was no significant difference in the renin activity
between UA-ARF and Non-UA-ARF groups.
Following unilateral nephrectomy, the serum creatinine con-
centration increased from 0.9 0.04 of the control value to 1.3
0.05 mg/100 ml (P < 0.01). In these animals, a two hour
clamping of the renal artery resulted in pronounced azotemia
(serum creatinine 7.2 0.89 mg/l0O ml) after three days, a time
at which renal injury has been found to be most remarkable
[20]. An additional ischemia also induced ARF in rabbits
recovering from prior ischemic ARF.
Glomerular reactivity to vasoconstrictor agents in vitro
The mean glomerular diameter did not significantly change in
the absence of a vasoconstrictor substance throughout the
observation periods (Tables 2, 3 and 4). Glomeruli derived from
normal kidneys displayed a contractile response to angiotensin
II within the range from 10-6 to 10_12 M, with the maximum
response at 20 minutes of the incubation time (Table 2). The
reduction in the mean glomerular diameter was not always
dose—dependent within the concentration range. The maximum
contraction evoked by the l0 M dose was 6% below control.
An addition of arginine vasopressin to glomeruli obtained from
normal rabbits resulted in a dose—related reduction in the
glomerular diameter, with the maximum response at 10 minutes
of the incubation time (Table 3). The maximum reduction in the
glomerulardiameter occurring to the 106, l0-, 10-10 and 10_12
M doses averaged 6, 5, 5 and 3% of control values, respectively.
The 10—14 M dose was not effective in producing glomerular
contraction. Norepinephrine also produced glomerular contrac-
tion, with the maximum response at 20 minutes of the incuba-
tion time (Table 4). The maximum contraction evoked by the
iO, 10—6, 10—8 and 10—10 M doses was approximately 5, 5, 4
and 2% below controls, respectively.
Fourteen days after the initial injection of uranyl acetate, all
angiotensin II, arginine vasopressin, and norepinephrine pro-
duced glomerular contraction in Non-UA-ARF rabbits (Tables
2, 3 and 4). The degree of glomerular contraction was similar to
that in normal glomeruli. On the contrary, the glomeruli derived
from UA-ARF animals were refractory to contractile stimuli
(Tables 2, 3 and 4). Also, the glomeruli obtained from ischemic
ARF kidneys did not respond to a pharmacologic dose of
angiotensin II (Table 2).
Discussion
Rabbits recovering from uranyl acetate—induced ARF were
highly resistant to a rechallenge with a larger dose of the agent,
but animals having not experienced ARF following the initial
insult were not. The data suggest that the degree of resistance to
a rechallenge with uranium is related to severity of prior ARF.
In contrast, rabbits recovering from ischemic ARF. were not
resistant to an additional ischemia. These findings are compat-
ible with those in the previous studies [8, 21].
In the present experiment, the maximum glomerular contrac-
tion evoked by angiotensin II in normal rabbits was significantly
small when compared with that in rats [7]. The exact causes of
this difference remain unverified. It is unlikely that the glomer-
uli might have not been viable, because the glomeruli isolated
with our technique could grow in tissue culture dishes. A likely
alternative is that the difference in glomerular contractility
might be due to differences in animal species and incubation
medium. Also, these is a possibility that glomerular refractori-
ness to contractile stimuli in ARF rabbits might have been due
to intravascular debris and blood cells in their capillary lumen.
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However, morphologic observations did not disclose any intra-
vascular debris in the glomeruli in the recovery phase of ARF.
The mechanisms for acquired resistance to ARF are poorly
understood. Based on numerous data [22—28], Schor, Ichikawa,
and Brenner [23] proposed the view that angiotensin II and
vasopressin are potentially important regulators of mesangial
cell contraction, and thereby the glomerular filtering surface
area and ultrafiltration coefficient (hydraulic conductivity mul-
tiplied by filtration area). If this is correct, a loss of mesangial
cell contraction should prevent a reduction in the glomerular
filtration area and ultrafiltration coefficient by angiotensin or
vasopressin. Wilkes et al [7] have demonstrated that the
glomerular contractile response to angiotensin II is totally
prevented in rats recovering from glycerol—induced ARF, but
the response to dibutyryl cyclic AMP is well sustained. They
suggested that the loss of the glomerular response to angioten-
sin contributes, in part, to resistance to a subsequent renal
failure challenge in this model. In our study, however, an
angiotensin—converting enzyme inhibitor (captopril) did not
prevent uranium—induced ARF (unpublished data). Also, rab-
bits recovering from uranium—induced ARF showed a complete
inhibition of the glomerular contractile response not only to
angiotensin but also to vasopressin or norepinephrine. It is
unlikely, therefore, that resistance to ARF is largely due to the
loss of the glomerular contractile response to angiotensin.
Furthermore, no information is available concerning the
ultrafiltration coefficient following a second renal failure chal-
lenge. A controversy exists concerning a reduction in the
glomerular capillary surface area by mesangial cell contraction
129—31], Haley et al [29] noted that angiotensin II reduces the
mesangium area but does not alter the glomerular capillary
surface area, Zimmerhackl et al [31] demonstrated that alter-
ations of the ultrafiltration coefficient are not induced by
uniform capillary vasoconstriction mechanisms. In our uranium
model, glomerular ultrastructural alterations occurred after a
second renal failure challenge even in ARF-resistant rabbits
[32]. Also, animals recovering from ischemic ARF were not
resistant to an additional ischemic insult, despite a complete
inhibition of the glomcrular response to angiotensin II. These
data do not support the view that suppressed glomerular
contractility protects glomerular filtration against a subsequent
renal failure challenge in ARF animals via well—maintained
glomerular capillary surface area.
It remains a possibility that resistance to ARF is due to an
entirely different mechanism. One possibility would be the
resistance of already injured tubular cells to the influx of
calcium, which is a necessary prerequisite for cell death. A
number of studies [2, 8, 9] demonstrated that renal functional
resistance is associated with protection of regenerated tubular
cells against a second renal failure challenge, though it is not a
common feature of all models [10].
In summary, the glomerular contractile response to angioten-
sin II, vasopressin or norepinephrinc was totally inhibited in
rabbits recovering from uranium—induced ARF. These animals
were highly resistant to a rechallenge with a larger dose of the
agent. In contrast, animals recovering from ischemie ARF were
not resistant to an additional ischemia, despite suppressed
glomerular contractility. It is unlikely, therefore, that resistance
to ARE is largely attributed to suppressed glomerular contrac-
tility.
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